openPR Logo
Press release

Post Bariatric Hypoglycemia Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | RECORDATI GROUP, Xeris Pharmaceuticals, Eiger BioPharmaceuticals, Zealand Pharma, Vogenx, Inc.

12-02-2024 08:18 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Post Bariatric Hypoglycemia Market Forecasted to Surge

DelveInsight's "Post Bariatric Hypoglycemia Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Post Bariatric Hypoglycemia, historical and forecasted epidemiology as well as the Post Bariatric Hypoglycemia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.

To Know in detail about the Post Bariatric Hypoglycemia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Post Bariatric Hypoglycemia Market Forecast
https://www.delveinsight.com/sample-request/post-bariatric-hypoglycemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Some of the key facts of the Post Bariatric Hypoglycemia Market Report:
• The Post Bariatric Hypoglycemia market size was valued ~USD 200 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
• In November 2024, MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company specializing in innovative precision peptide therapies for endocrine and metabolic disorders, has announced the completion of the final subject's last visit in its Phase 1 trial. The study, which included single and multiple ascending doses, evaluated MBX 1416, the company's long-acting glucagon-like peptide 1 (GLP-1) receptor antagonist, being developed to treat post-bariatric hypoglycemia (PBH).
• Among the emerging treatments, Eiger BioPharmaceuticals' AVEXITIDE is projected to achieve the largest market size during the forecast period (2024-2034).
• In 2023, the total number of postbariatric hypoglycemia cases across the 7MM was estimated at around 110,000, and according to DelveInsight's projections, this number is expected to rise by 2034.
• In 2023, the US represented the largest share of postbariatric hypoglycemia cases, accounting for approximately 80% of the total cases.
• According to DelveInsight's analysis, in 2023, sleeve gastrectomy cases had the highest incidence of postbariatric hypoglycemia in the US, followed by Roux-en-Y gastric bypass cases, with other surgical approaches showing fewer cases.
• In 2023, over 90% of postbariatric hypoglycemia cases in the United States were classified as mild to moderate in severity.
• In 2023, approximately 50,000 cases of postbariatric hypoglycemia were treated in the United States.
• Key Post Bariatric Hypoglycemia Companies: RECORDATI GROUP, Xeris Pharmaceuticals, Eiger BioPharmaceuticals, Zealand Pharma, Vogenx, Inc., and others
• Key Post Bariatric Hypoglycemia Therapies: Pasireotide Diaspartate, glucagon, Lyo avexitide, Dasiglucagon, Mizagliflozin, G-Pump™ (glucagon infusion), Avexitide, and others
• The Post Bariatric Hypoglycemia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Post Bariatric Hypoglycemia pipeline products will significantly revolutionize the Post Bariatric Hypoglycemia market dynamics.

Post Bariatric Hypoglycemia Overview
Post-bariatric hypoglycemia (PBH) is a condition that can occur after weight loss surgery, also known as bariatric surgery. This condition involves episodes of low blood sugar (hypoglycemia) that typically happen one to three hours after eating. Post-bariatric hypoglycemia is more commonly associated with certain types of weight loss procedures, such as gastric bypass surgery.

Get a Free sample for the Post Bariatric Hypoglycemia Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/post-bariatric-hypoglycemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Post Bariatric Hypoglycemia Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Post Bariatric Hypoglycemia Epidemiology Segmentation:
The Post Bariatric Hypoglycemia market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:
• Total Prevalence of Post Bariatric Hypoglycemia
• Prevalent Cases of Post Bariatric Hypoglycemia by severity
• Gender-specific Prevalence of Post Bariatric Hypoglycemia
• Diagnosed Cases of Episodic and Chronic Post Bariatric Hypoglycemia

Download the report to understand which factors are driving Post Bariatric Hypoglycemia epidemiology trends @ Post Bariatric Hypoglycemia Epidemiology Forecast
https://www.delveinsight.com/sample-request/post-bariatric-hypoglycemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Post Bariatric Hypoglycemia Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Post Bariatric Hypoglycemia market or expected to get launched during the study period. The analysis covers Post Bariatric Hypoglycemia market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Post Bariatric Hypoglycemia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Post Bariatric Hypoglycemia Therapies and Key Companies
• Pasireotide Diaspartate: RECORDATI GROUP
• glucagon: Xeris Pharmaceuticals
• Lyo avexitide: Eiger BioPharmaceuticals
• Dasiglucagon: Zealand Pharma
• Mizagliflozin: Vogenx, Inc.
• G-Pump™ (glucagon infusion): Xeris Pharmaceuticals
• Avexitide: Eiger BioPharmaceuticals

Discover more about therapies set to grab major Post Bariatric Hypoglycemia market share @ Post Bariatric Hypoglycemia Treatment Landscape
https://www.delveinsight.com/sample-request/post-bariatric-hypoglycemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Scope of the Post Bariatric Hypoglycemia Market Report
• Study Period: 2020-2034
• Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
• Key Post Bariatric Hypoglycemia Companies: RECORDATI GROUP, Xeris Pharmaceuticals, Eiger BioPharmaceuticals, Zealand Pharma, Vogenx, Inc., and others
• Key Post Bariatric Hypoglycemia Therapies: Pasireotide Diaspartate, glucagon, Lyo avexitide, Dasiglucagon, Mizagliflozin, G-Pump™ (glucagon infusion), Avexitide, and others
• Post Bariatric Hypoglycemia Therapeutic Assessment: Post Bariatric Hypoglycemia current marketed and Post Bariatric Hypoglycemia emerging therapies
• Post Bariatric Hypoglycemia Market Dynamics: Post Bariatric Hypoglycemia market drivers and Post Bariatric Hypoglycemia market barriers
• Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
• Post Bariatric Hypoglycemia Unmet Needs, KOL's views, Analyst's views, Post Bariatric Hypoglycemia Market Access and Reimbursement

To know more about Post Bariatric Hypoglycemia companies working in the treatment market, visit @ Post Bariatric Hypoglycemia Clinical Trials and Therapeutic Assessment
https://www.delveinsight.com/sample-request/post-bariatric-hypoglycemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1. Post Bariatric Hypoglycemia Market Report Introduction
2. Executive Summary for Post Bariatric Hypoglycemia
3. SWOT analysis of Post Bariatric Hypoglycemia
4. Post Bariatric Hypoglycemia Patient Share (%) Overview at a Glance
5. Post Bariatric Hypoglycemia Market Overview at a Glance
6. Post Bariatric Hypoglycemia Disease Background and Overview
7. Post Bariatric Hypoglycemia Epidemiology and Patient Population
8. Country-Specific Patient Population of Post Bariatric Hypoglycemia
9. Post Bariatric Hypoglycemia Current Treatment and Medical Practices
10. Post Bariatric Hypoglycemia Unmet Needs
11. Post Bariatric Hypoglycemia Emerging Therapies
12. Post Bariatric Hypoglycemia Market Outlook
13. Country-Wise Post Bariatric Hypoglycemia Market Analysis (2020-2034)
14. Post Bariatric Hypoglycemia Market Access and Reimbursement of Therapies
15. Post Bariatric Hypoglycemia Market Drivers
16. Post Bariatric Hypoglycemia Market Barriers
17. Post Bariatric Hypoglycemia Appendix
18. Post Bariatric Hypoglycemia Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight

Related Reports:
Post Bariatric Hypoglycemia Epidemiology https://www.delveinsight.com/report-store/post-bariatric-hypoglycemia-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Post Bariatric Hypoglycemia Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Post Bariatric Hypoglycemia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Reports by DelveInsight
• Pd-1 & Pdl1 Market: https://www.delveinsight.com/report-store/pd-1-and-pd-l1-inhibitors-competitive-landscape
• Cervical Dysplasia Market: https://www.delveinsight.com/report-store/cervical-dysplasia-market-insights
• Hypogonadism Market: https://www.delveinsight.com/report-store/hypogonadism-market
• Acoustic Neuroma Market: https://www.delveinsight.com/report-store/acoustic-neuroma-market
• Non-hodgkin's Lymphoma Market: https://www.delveinsight.com/report-store/non-hodgkins-lymphoma-market
• Substance Use Disorder Market: https://www.delveinsight.com/report-store/substance-use-disorder-market
• Transcatheter Heart Valve Replacement Devices Market: https://www.delveinsight.com/report-store/transcatheter-aortic-valve-replacement-market

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email: info@delveinsight.com
Contact No.: +91-9650213330
City: 304 S. Jones Blvd #2432, Las Vegas
State: Nevada (89107)
Country: United States
Website: https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Post Bariatric Hypoglycemia Market Forecasted to Surge in Coming Years, 2024-2034 Analysis by DelveInsight | RECORDATI GROUP, Xeris Pharmaceuticals, Eiger BioPharmaceuticals, Zealand Pharma, Vogenx, Inc. here

News-ID: 3767074 • Views:

More Releases from DelveInsight Business Research

Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibrillation Space by DelveInsight
Pharma Asset Management Success Story: Strategic In-Licensing in the Atrial Fibr …
DelveInsight, a leading business consulting and market research firm, is pleased to announce the successful completion of an Asset Prioritization project that enabled a mid-sized pharmaceutical client to identify, evaluate, and secure a high-value therapeutic asset for in-licensing in the Atrial Fibrillation (AF) space. The case study highlights how evidence-based insights, structured methodologies, and multi-layered evaluations supported the client in achieving its long-term strategic growth goals. Objective of the Case Study The
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestones, Therapies in Development, Mechanisms of Action, and Routes of Administration - By DelveInsight
Myopia Clinical Trials Outlook 2025: Competitive Landscape, Regulatory Milestone …
(Albany, USA) - DelveInsight's newly released report, "Myopia Pipeline Insight 2025," delivers an in-depth assessment of the clinical trial landscape, regulatory progress, and therapeutic development trends shaping the Myopia therapeutics market. The analysis highlights ongoing clinical advancements, pipeline opportunities, and the potential impact of emerging therapies on patient care and market dynamics. According to DelveInsight's evaluation, the Myopia pipeline remains highly active, with 8+ pharmaceutical and biotechnology companies investigating more than
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Rising Cancer Burden and Technological Advancements, states DelveInsight
Global Biopsy Devices Market to Reach USD 10.81 Billion by 2032, Driven by Risin …
The global biopsy devices market is poised for significant growth, with market size projected to increase from USD 5,813.16 million in 2024 to USD 10,812.77 million by 2032, expanding at a CAGR of 8.09% during 2025-2032. The robust expansion is being driven by the growing incidence of cancers, rising demand for minimally invasive diagnostic procedures, and rapid advancements in biopsy technologies. Biopsy devices play a crucial role in disease diagnosis by
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven by Rising Surgical Procedures, Technological Advancements, and Growing Adoption of Minimally Invasive Techniques, States DelveInsight
Global General Surgery Devices Market to Reach USD 35.4 Billion by 2032, Driven …
According to the latest market analysis, the global general surgery devices market is set for robust growth, increasing from USD 21,786.29 million in 2024 to USD 35,399.63 million by 2032, expanding at a CAGR of 6.34% during 2025-2032. This growth reflects a surge in surgical procedures, continuous technological advancements, and rising demand for minimally invasive and robotic-assisted surgical techniques across healthcare systems worldwide. DelveInsight's General Surgery Devices Market Report 2032 provides

All 5 Releases


More Releases for Post

Post-Tensioning System Market Next Big Thing | Major Giants Freyssinet, Suncoast …
Latest added Post-Tensioning System Market research study by AMA Research offers detailed outlook and elaborates market review till 2026. The market Study is segmented by key regions that are accelerating the marketization. At present, the market players are strategizing and overcoming challenges of current scenario; some of the key players in the study are VSL International Ltd. (Switzerland), Freyssinet (France), DYWIDAG-Systems International (Germany), Suncoast Post-Tension (United States), SRG Limited (Australia),
Postal Operators Market Future Outlook to 2025: USPS, Japan Post, Deutsche Post, …
Research for Market in this report on the Global Postal Operators Market will continue to be interested in CAGR growth by providing an in-depth look at how major players and brands are driving the Postal Operators Market during the 2019-2025 forecast period. In addition, the Postal Operators Market definition, classification, application and participation of the Global Postal Operators Market was described. The Global Postal Operators Market is categorized by market
Postal Operators Market Future Outlook to 2025: USPS, Japan Post, Deutsche Post, …
Research For Market in this report on Global Postal Operators Market will keep you apprised in this CAGR growing market by letting you know in-depth how the key players and brands are driving the market in the forecast period of 2019-2025. Further, the markets definition, classifications, applications, and engagements in the Global Postal Operators Market have been described. The Global Postal Operators Market has been classified according to market size
Parcel Delivery Market Wide Spread Across the World | China Post, Deutsche Post …
HTF MI recently introduced Global Parcel Delivery Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are China Post, Deutsche Post DHL, FedEx, Japan Post Group, La Poste
E Commerce Logistics Market Outlook 2023 – FedEx, Australia Post, Blue Dart, C …
E-commerce is the activity of buying or selling of products on online services or over the Internet. There are many factors that augment the growth of global E commerce logistics market such as growing E commerce market, smaller and simple supply chain, new and innovative methods of deliveries and so on. The report comprises the study of the global e-commerce logistics market that focuses on various types of services in the market.
Parcel Delivery Market is Booming Worldwide | Deutsche Post DHL, FedEx, Japan Po …
HTF MI recently introduced Global Parcel Delivery Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are China Post, Deutsche Post DHL, FedEx, Japan Post Group, La Poste